TY  - GEN
AU  - Janni,Wolfgang
AU  - Sarosiek,Tomasz
AU  - Karaszewska,Boguslawa
AU  - Pikiel,Joanna
AU  - Staroslawska,Elzbieta
AU  - Potemski,Piotr
AU  - Salat,Christoph
AU  - Brain,Etienne
AU  - Caglevic,Christian
AU  - Briggs,Kathryn
AU  - Mahood,Kim
AU  - DeSilvio,Michelle
AU  - Marini,Luca
AU  - Papadimitriou,Christos
TI  - Final overall survival analysis of a phase II trial evaluating vinorelbine and lapatinib in women with ErbB2 overexpressing metastatic breast cancer
SN  - 1532-3080
PY  - 2016///0901
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Breast Neoplasms
KW  - chemistry
KW  - Disease-Free Survival
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Lapatinib
KW  - Lymphatic Metastasis
KW  - Middle Aged
KW  - Quinazolines
KW  - Receptor, ErbB-2
KW  - analysis
KW  - Survival Analysis
KW  - Treatment Outcome
KW  - Vinblastine
KW  - Vinorelbine
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.breast.2015.08.005
ER  -